LEADER 06697nam 2200673Ia 450 001 9910973620303321 005 20251117065807.0 010 $a1-61122-383-0 035 $a(CKB)2670000000092445 035 $a(EBL)3018655 035 $a(SSID)ssj0000524411 035 $a(PQKBManifestationID)11355966 035 $a(PQKBTitleCode)TC0000524411 035 $a(PQKBWorkID)10547460 035 $a(PQKB)10162259 035 $a(MiAaPQ)EBC3018655 035 $a(Au-PeEL)EBL3018655 035 $a(CaPaEBR)ebr10661593 035 $a(OCoLC)726743253 035 $a(BIP)32205586 035 $a(EXLCZ)992670000000092445 100 $a20100823d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeuroplasticity in the auditory brainstem $efrom physiology to the drug therapy /$fAngelo Salami. editor 205 $a1st ed. 210 $aNew York $cNova Science Publishers$dc2011 215 $a1 online resource (191 p.) 225 1 $aNeurology : laboratory and clinical research developments 225 1 $aPharmacology : research, safety testing and regulation 300 $aDescription based upon print version of record. 311 08$a1-61761-949-3 320 $aIncludes bibliographical references and index. 327 $aIntro -- NEUROPLASTICITY IN THE AUDITORY BRAINSTEM: FROM PHYSIOLOGY TO THE DRUG THERAPY -- NEUROPLASTICITY IN THE AUDITORY BRAINSTEM: FROM PHYSIOLOGY TO THE DRUG THERAPY -- Contents -- Introduction -- Chapter I Anatomy of the Auditory Pathway -- Abstract -- 1. The Inner Ear -- 2. The Auditory Nerve -- 3. The Central Auditory Pathway -- 3.1. The Cochlear Nuclear Complex (CNC) -- 3.2. Superior Olivary Complex (SOC) -- 3.3. Inferior Colliculus (IC) -- 4. Central Pathways and Cortical Projections -- 5. The Primary Auditory Cortex (PAC, AI) -- 6. Efferent Projections -- 6.1. From the AC to both the MBG and IC -- 6.2. From the IC to both Cochlear Nuclei (CN) and the SOC -- 6.3. From the SOC to the Hair Cells -- References -- Chapter II Phsyiology of the Central Auditory System -- Introduction -- Central Auditory Processing Strategies -- Spontaneous Rat -- Intensity Coding -- Frequency Coding -- Temporal Coding -- Sound Localization -- Complex Stimuli -- Variation in the Physiology of the Normal Central Auditory Pathway -- Anesthesia -- Development -- Attention -- Conclusions -- Acknowledgments -- References -- Chapter III Neurobiology of Age Related Hearing Loss -- Abstract -- Introduction -- Neurobiology -- Neurotrophins -- Mitochondrial Modifications -- Other Mechanisms of Mitochondrial Damage are Related to Lipid Oxidation and Protein Oxidation -- Discussion -- Conclusion -- References -- Chapter IV Neuroplasticity in the Auditory System after Hearing Loss -- Abstract -- Introduction -- Molecular Mechanisms of Neuroplasticity -- Neuroplasticity and Auditory System -- Neurons, Growth Cones and Neuroplasticity -- Neuroplasticity and Experimental Deafness by Cochlear Induced Lesion -- 1. First Phase: Acute Cochlear Nuclei Degeneration [5,6] -- 2. Second Phase: Stabilization of Lesions and Neuroplasticity. 327 $a3. Third Phase: Neuroplasticity and CN Reorganization -- Conclusion -- Acknowledgments -- References -- Chapter V Hearing Loss and Balance Dysfunction in Children -- Introduction -- Sensorineural Hearing Loss -- 1. Balance and Vestibular Dysfunction in SHNL -- 2. Cochlear Implantation and Vestibular Function -- Conductive Hearing Loss -- Rehabilitation of Balance and Motor Skills in the Hearing Impaired Child -- Conclusion -- References -- Chapter VI The Effect of Brain Plasticity on the Results of Cochlear Implantation -- Abstract -- 1. The Importance of Brain Research in Deaf Patients -- 2. Cross-Modal Plasticity -- 3. Method Used to Evaluate Human Brain Function -- 4. PET Studies in Deaf Patients -- 4.1. Cortical Metabolism in Prelingually Deaf Children -- 4.2. Cortical Metabolism in Postlingually Deaf Adults -- 4.3. The Association between Cortical Metabolism and Post-implant Speech Perception in the Prelingually Deaf -- 4.4. Changes in Cortical Metabolism after Cochlear Implantation -- 5. Changes in Cognitive Function in Deaf Patients -- 6. Studies Using Deaf Animal Models -- 6.1. Changes in Auditory Cortex Metabolism in the White Rat Model -- 6.2. Molecular Changes in the Auditory Cortex of a Deaf White Rat Model -- 6.3. Electrophysiologic and Metabolic Changes in the Auditory Cortex in a Deaf Cat Model -- 7. Summary and Future Research Directions -- Conclusion -- Acknowledgments -- References -- Chapter VII Pharmacology of New Drugs Used to Improve the Neuroplasticity of the Central Auditory Pathway -- Abstract -- Introduction -- Coenzyme Q10 -- Basic Pharmacology and Toxicity -- Coenzyme Q10 and Neuroprotection -- Experimental and Clinical Data -- Q-TER®: A Water-soluble Formulation of CoQ10 -- Citicoline -- Synthesis of Membrane Phospholipids -- Neurotransmitter Production -- Basic Pharmacology and Toxicity. 327 $aExperimental and Clinical Data -- Conclusion -- References -- Chapter VIII New Drugs to Improve the Neuroplasticity of the Central Auditory Pathway -- Abstract -- Introduction -- Antioxidant Agents -- Methods -- Results -- Discussion -- Conclusion -- References -- Chapter IX Central Auditory System Neuroplasticity and Hippocampal Neurogenesis following Cochlear Insults -- Abstract -- Introduction -- Salicylate-Induced Cochlear Insult -- Acute Salicylate Exposure -- Chronic Salicylate Exposure -- Carboplatin-induced Ototoxicity -- Acoustic Overstimulation -- Conclusion -- Acknowledgments -- References -- Index -- Blank Page. 330 $aAccording to the theory of neuroplasticity, thinking, learning, acting and hearing can change both the brain's physical structure and functional organisation according to the peripheral stimuli. This book reviews the knowledge on the neuroplasticity in the auditory brainstem: from physiology to the drug therapy. 410 0$aNeurology--laboratory and clinical research development series. 410 0$aPharmacology-research, safety testing, and regulation series. 606 $aAuditory pathways 606 $aNeuroplasticity 606 $aBrain stem 606 $aCochlear implants 615 0$aAuditory pathways. 615 0$aNeuroplasticity. 615 0$aBrain stem. 615 0$aCochlear implants. 676 $a612.8/5 701 $aSalami$b Angelo$01867066 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910973620303321 996 $aNeuroplasticity in the auditory brainstem$94474493 997 $aUNINA LEADER 01175nam0 2200301 i 450 001 VAN00068855 005 20240806100545.779 010 $a88-7104-800-8 100 $a20090415d1994 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| ||||| 200 1 $aˆIl ‰teatro antico$fPierre Grimal - Napoli$eEdizioni scientifiche italiane, 1994 210 $a108 p.$a18 cm 215 $aTrad. di Patrizio O'Connor. 410 1$1001VAN00068858$12001 $aChe so?$1210 $aNapoli$cEdizioni scientifiche italiane.$v34 606 $aLETTERATURA DRAMMATICA GRECA$3VANC017437$2FI 606 $aTEATRO$3VANC026120$2FI 620 $dNapoli$3VANL000005 700 1$aGrimal$bPierre$3VANV015179$037706 702 1$aO'Connor$bPatrizio$3VANV054442 712 $aESI $3VANV108662$4650 801 $aIT$bSOL$c20260130$gRICA 899 $aBIBLIOTECA DEL DIPARTIMENTO DI LETTERE E BENI CULTURALI$1IT-CE0103$2VAN07 912 $aVAN00068855 950 $aBIBLIOTECA DEL DIPARTIMENTO DI LETTERE E BENI CULTURALI$d07CONS Xa 877 $e07 4288 20090415 996 $aTeatro antico$9816800 997 $aUNICAMPANIA